The prevalence of electronic products has caused frequent occurrence of eye diseases such as myopia, glaucoma, and dry eye. The market demand for ophthalmic drugs is increasing. Among ophthalmic drugs, drops are the majority. Therefore, the market demand for eye drop bottles is also following expand.
At present, the main ophthalmic diseases include myopia, dry eye, glaucoma, cataracts and fundus vascular disease. The main diseases of fundus vascular disease include age-related macular degeneration, diabetic macular edema, choroidal neovascularization and retinal vein secondary to pathological myopia block.
According to Frost & Sullivan statistics, the global ophthalmic medicine market has grown from USD 24.7 billion in 2015 to USD 33.7 billion in 2019, with a compound growth rate of 8.0%. According to Alcon, Inc., the world's leading ophthalmic medical company, the global market for ophthalmic medical devices and vision care products reached USD 23 billion in 2017. The compound growth rate from 2018 to 2023 is expected to be 4%, of which 2017 The eye surgery market is about 9 billion U.S. dollars, and the vision care market in 2017 was about 14 billion U.S. dollars, and the compound growth rate from 2018 to 2023 is expected to be 4%. If the market size of ophthalmic drugs and the market size of ophthalmic medical devices and vision care products are superimposed as the overall ophthalmology market size, the global ophthalmology market in 2019 will be approximately 58.6 billion U.S. dollars (excluding ophthalmology).
The eye drop bottle is a special pharmaceutical packaging for ophthalmic drop drugs, which is very important to the safety and stability of the drug. Such a huge market for ophthalmic drugs will greatly drive the market demand for eye drop bottles.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
